<?xml version="1.0" encoding="UTF-8"?>
<p>Based on these preclinical effects of 
 <italic>C. longa</italic>, it can be used as therapeutic candidates for the treatment of toxic hepatitis, alcoholic liver disease, nonalcoholic fatty liver disease, cirrhosis, liver cancer, and cholestatic liver diseases. Regarding the molecular mechanism of 
 <italic>C. longa</italic> in treating hepatobiliary diseases, further investigations on its role as a PPAR-
 <italic>Î³</italic> agonist are needed, which might contribute to regulating inflammation, fibrosis, and cancer. Although the optimal extraction method of 
 <italic>C. longa</italic> is inconclusive, it is necessary to find an extraction process which can maximize the acquisition of its active constituents.
</p>
